CAMPTOTHECINS

被引：16

作者：

CHABNER, BA

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1992年 / 10卷 / 01期

关键词：

D O I：

10.1200/JCO.1992.10.1.3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3 / 4

页数：2

共 14 条

[1] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J].

ANDOH, T ;

ISHII, K ;

SUZUKI, Y ;

IKEGAMI, Y ;

KUSUNOKI, Y ;

TAKEMOTO, Y ;

OKADA, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5565-5569

[2] CAMPTOTHECIN-STABILIZED TOPOISOMERASE-I-DNA ADDUCTS CAUSE PREMATURE TERMINATION OF TRANSCRIPTION [J].

BENDIXEN, C ;

THOMSEN, B ;

ALSNER, J ;

WESTERGAARD, O .

BIOCHEMISTRY, 1990, 29 (23) :5613-5619

[3]

COVEY JM, 1989, CANCER RES, V49, P5016

[4] A PHASE-II STUDY OF CPT-11, A NEW DERIVATIVE OF CAMPTOTHECIN, FOR PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER [J].

FUKUOKA, M ;

NIITANI, H ;

SUZUKI, A ;

MOTOMIYA, M ;

HASEGAWA, K ;

NISHIWAKI, Y ;

KURIYAMA, T ;

ARIYOSHI, Y ;

NEGORO, S ;

MASUDA, N ;

NAKAJIMA, S ;

TAGUCHI, T ;

ASAKAWA, M ;

NAKABAYASI, T ;

NAKAI, T ;

KURITA, Y ;

KINAMERI, K ;

NOMURA, K ;

NAGAO, K ;

SAIJO, N ;

OHE, Y ;

SUGIURA, T ;

SHIMOKATA, K ;

SAKA, H ;

NEGORO, S ;

NAKAJIMA, S ;

TOHDA, Y ;

FUJII, M ;

OTA, M ;

HARA, N ;

HARA, Y ;

FUJISAWA, K ;

NAKANO, S ;

ARAKI, J ;

NIITANI, H ;

MIYATA, Y .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :16-20

[5]

GIOVANELLA BC, 1991, CANCER RES, V51, P3052

[6]

GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461

[7]

GUPTA RS, 1988, CANCER RES, V48, P6404

[8]

HSIANG YH, 1985, J BIOL CHEM, V260, P4873

[9]

KAUFMANN SH, 1991, CANCER RES, V51, P1129

[10] INHIBITION OF REPLICON INITIATION IN HUMAN-CELLS FOLLOWING STABILIZATION OF TOPOISOMERASE-DNA CLEAVABLE COMPLEXES [J].

KAUFMANN, WK ;

BOYER, JC ;

ESTABROOKS, LL ;

WILSON, SJ .

MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (07) :3711-3718

← 1 2 →